Following approvals in the US and Europe this month of a new drug to treat hepatitis C, activists are pushing for the medication to be made available in poor countries, a development reminiscent of the activism that forced down HIV/AIDS drug prices a decade ago in Brazil, South Africa and Thailand.
http://allafrica.com/stories/201312240089.html
http://allafrica.com/stories/201312240089.html
No comments:
Post a Comment